Imeri, J. Et Al. 2022. Modeling Progression of CML Using Mutagenized Patient-Derived Induced Pluripotent Stem Cells (iPSCs): Potential Tool for Discovering Novel Therapeutic Targets. 64th American Society of Hematology Meeting , (New Orleans, United States Of America), 12173-12174.

Imeri, J., Desterke, C., Telliam, G., Marcoux, P., Sorel, N., Sanekli, S., ... Barreau, S.(2022). Modeling Progression of CML Using Mutagenized Patient-Derived Induced Pluripotent Stem Cells (iPSCs): Potential Tool for Discovering Novel Therapeutic Targets . 64th American Society of Hematology Meeting (pp.12173-12174). New Orleans, United States Of America

Imeri, Jusuf Et Al. "Modeling Progression of CML Using Mutagenized Patient-Derived Induced Pluripotent Stem Cells (iPSCs): Potential Tool for Discovering Novel Therapeutic Targets," 64th American Society of Hematology Meeting, New Orleans, United States Of America, 2022

Imeri, Jusuf Et Al. "Modeling Progression of CML Using Mutagenized Patient-Derived Induced Pluripotent Stem Cells (iPSCs): Potential Tool for Discovering Novel Therapeutic Targets." 64th American Society of Hematology Meeting , New Orleans, United States Of America, pp.12173-12174, 2022

Imeri, J. Et Al. (2022) . "Modeling Progression of CML Using Mutagenized Patient-Derived Induced Pluripotent Stem Cells (iPSCs): Potential Tool for Discovering Novel Therapeutic Targets." 64th American Society of Hematology Meeting , New Orleans, United States Of America, pp.12173-12174.

@conferencepaper{conferencepaper, author={Jusuf Imeri Et Al. }, title={Modeling Progression of CML Using Mutagenized Patient-Derived Induced Pluripotent Stem Cells (iPSCs): Potential Tool for Discovering Novel Therapeutic Targets}, congress name={64th American Society of Hematology Meeting}, city={New Orleans}, country={United States Of America}, year={2022}, pages={12173-12174} }